CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Galderma Laboratories LP v. Taro Pharmaceuticals USA Inc

3:15-cv-02814

Overview

Case Number 3:15-cv-02814
Filing Date 2015-08-28
Status Terminated
Termination Date 2015-11-09
Court District Court, N.D. Texas (txnd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Taro Pharmaceuticals USA Inc Operating Company

Represented By

1 Attorneys Listed

Jerry R Selinger

Patterson & Sheridan LLP

Tel: +1 (214) 720-2200
Fax: +1 (214) 296-0246

1700 Pacific Avenue, Suite 2650, Dallas, TX 75201

Plaintiff

Galderma Research & Development SNC Operating Company

Represented By

5 Attorneys Listed

Kelly P Chen

Munck Wilson Mandala LLP

Tel: +1 (972) 628-3683
Fax: +1 (972) 628-3616

12770 Coit Road, Suite 600, Dallas, TX 75251

Jordan Christine Strauss

Munck Wilson Mandala LLP

Tel: +1 (972) 628-3600
Fax: +1 (972) 628-3616

2000 McKinney Avenue, Suite 1900

Jamil N Alibhai

Munsch Hardt Kopf and Harr

Tel: +1 (214) 880-1061
Fax: +1 (214) 855-7584

Munsch Hardt Kopf and Harr, 500 N Akard Street

Daniel E Venglarik

Munck Wilson Mandala LLP

Tel: +1 (972) 628-3600
Fax: +1 (972) 628-3616

12770 Coit Road, Suite 600, Dallas, TX 75251

Michael C Wilson

Munck Wilson Mandala LLP

Tel: +1 (972) 628-3600
Fax: +1 (972) 628-3616

2000 McKinney Avenue, Suite 1900, Dallas, TX 75201

Galderma SA NPE (Individual / Inventor)

Represented By

5 Attorneys Listed

Kelly P Chen

Munck Wilson Mandala LLP

Tel: +1 (972) 628-3683
Fax: +1 (972) 628-3616

12770 Coit Road, Suite 600, Dallas, TX 75251

Jordan Christine Strauss

Munck Wilson Mandala LLP

Tel: +1 (972) 628-3600
Fax: +1 (972) 628-3616

2000 McKinney Avenue, Suite 1900

Jamil N Alibhai

Munsch Hardt Kopf and Harr

Tel: +1 (214) 880-1061
Fax: +1 (214) 855-7584

Munsch Hardt Kopf and Harr, 500 N Akard Street

Daniel E Venglarik

Munck Wilson Mandala LLP

Tel: +1 (972) 628-3600
Fax: +1 (972) 628-3616

12770 Coit Road, Suite 600, Dallas, TX 75251

Michael C Wilson

Munck Wilson Mandala LLP

Tel: +1 (972) 628-3600
Fax: +1 (972) 628-3616

2000 McKinney Avenue, Suite 1900, Dallas, TX 75201

Galderma Laboratories LP NPE (Individual / Inventor)

Represented By

5 Attorneys Listed

Kelly P Chen

Munck Wilson Mandala LLP

Tel: +1 (972) 628-3683
Fax: +1 (972) 628-3616

12770 Coit Road, Suite 600, Dallas, TX 75251

Jordan Christine Strauss

Munck Wilson Mandala LLP

Tel: +1 (972) 628-3600
Fax: +1 (972) 628-3616

2000 McKinney Avenue, Suite 1900

Jamil N Alibhai

Munsch Hardt Kopf and Harr

Tel: +1 (214) 880-1061
Fax: +1 (214) 855-7584

Munsch Hardt Kopf and Harr, 500 N Akard Street

Daniel E Venglarik

Munck Wilson Mandala LLP

Tel: +1 (972) 628-3600
Fax: +1 (972) 628-3616

12770 Coit Road, Suite 600, Dallas, TX 75251

Michael C Wilson

Munck Wilson Mandala LLP

Tel: +1 (972) 628-3600
Fax: +1 (972) 628-3616

2000 McKinney Avenue, Suite 1900, Dallas, TX 75201

Court & Judges

Court

District Court, N.D. Texas (txnd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 10 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (10): FR 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

5 Patents

There are 5 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8071644
Combinations of adapalene and benzoyl peroxide for treating acne lesions
Filed: 2009-01-13
Issued: 2011-12-06
Active (0.8 yrs remaining)
Expires: 2027-09-04
US8080537
Combinations of adapalene and benzoyl peroxide for treating acne lesions
Filed: 2009-05-28
Issued: 2011-12-20
Active (0.7 yrs remaining)
Expires: 2027-07-18
US8129362
Combination/association of adapalene and benzoyl peroxide for treating acne lesions
Filed: 2007-07-13
Issued: 2012-03-06
Active (2.1 yrs remaining) +548d PTA
Expires: 2029-01-11
US8445543
Combinations of adapalene and benzoyl peroxide for treating acne lesions
Filed: 2011-11-30
Issued: 2013-05-21
Active (5.0 yrs remaining)
Expires: 2031-11-30
US8809305
Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris
Filed: 2009-07-29
Issued: 2014-08-19
Active (4.0 yrs remaining) +488d PTA
Expires: 2030-11-29

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(11 total)
Pleading / Complaint

COMPLAINT against Taro Pharmaceuticals USA Inc filed by Galderma Laboratories LP, Galderma SA, Galderma Research & Development SNC. (Filing fee $400; Receipt number 0539-7025628) Clerk to issue summons(es). In each Notice of Electronic Filing, the judge assignment is indicated, and a link to the Judges Copy Requirements is provided. The court reminds the filer that any required copy of this and future documents must be delivered to the judge, in the manner prescribed, within three business days of filing. Unless exempted, attorneys who are not admitted to practice in the Northern District of Texas must seek admission promptly. Forms, instructions, and exemption information may be found at www.txnd.uscourts.gov, or by clicking here: Attorney Information - Bar Membership. If admission requirements are not satisfied within 21 days, the clerk will notify the presiding judge. (Attachments: # 1 Exhibit(s) Ex. A - pat 8,071,644, # 2 Exhibit(s) Ex. B - pat 8,080,537, # 3 Exhibit(s) Ex. C - pat 8,129,362, # 4 Exhibit(s) Ex. D - pat 8,445,543, # 5 Exhibit(s) Ex. E - pat 8,809,305, # 6 Cover Sheet) (Wilson, Michael) (Entered: 08/28/2015)

Entry #1 • 2015-08-28
1

CERTIFICATE OF INTERESTED PERSONS/DISCLOSURE STATEMENT by Galderma Laboratories LP, Galderma Research & Development SNC, Galderma SA. (Wilson, Michael) (Entered: 08/28/2015)

Entry #2 • 2015-08-28
1
Court Order

New Case Notes: A filing fee has been paid. File to Judge Fish. Pursuant to Misc. Order 6, Plaintiff is provided the Notice of Right to Consent to Proceed Before A U.S. Magistrate Judge (Judge Horan). Clerk to provide copy to plaintiff if not received electronically. (axm) (Entered: 08/28/2015)

Entry #3 • 2015-08-28
1

Summons Issued as to Taro Pharmaceuticals USA Inc. (axm) (Entered: 08/28/2015)

Entry #4 • 2015-08-28
1

Report to Patent/Trademark Office of Initiating Document. Form AO 120 e-mailed to notice_of_suit@uspto.gov. (axm) (Entered: 08/28/2015)

Entry #5 • 2015-08-28
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc